Serina Therapeutics, Inc. Finance Lease, Right-of-Use Asset, after Accumulated Amortization
Serina Therapeutics, Inc. (SER) had Finance Lease, Right-of-Use Asset, after Accumulated Amortization of $0 as of 2025-12-31, per its 10-K filed 2026-03-25.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:FinanceLeaseRightOfUseAsset · last filed 2026-03-25
- 2025-12-31: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $0.00.
- 2025-09-30: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $0.00.
- 2025-06-30: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $0.00.
- 2025-03-31: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $81.00K.
| Period end | Finance Lease, Right-of-Use Asset, after Accumulated Amortization |
|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-25 |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-13 |
| 2025-06-30 | $0.00 10-Q · filed 2025-08-11 |
| 2025-03-31 | $81.00K 10-Q · filed 2025-05-08 |
| 2024-12-31 | $86.00K 10-K · filed 2026-03-25 |
| 2024-09-30 | $92.00K 10-Q · filed 2024-11-12 |
| 2024-06-30 | $98.00K 10-Q · filed 2024-08-09 |
| 2024-03-31 | $104.00K 10-Q · filed 2024-05-14 |
| 2023-12-31 | $110.00K 10-K · filed 2025-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| TALPHERA, INC. (TLPH) | United States | $0.060B |